The inflammatory response in pediatric biliary disease: Macrophage phenotype and distribution

Journal of Pediatric Surgery

Volumn 31, Issue 1, 1996, Pages 121-126

  Tracy Jr , Thomas F ^a   Dillon, Peter ^b   Fox, Eben S ^b   Minnick, Kathleen ^b   Vogler, Carole ^b  

^a Cardinal Glennon Hospital   (United States)

^b NONE

Author keywords

biliary atresia; cholangitis; endotoxin; Kupffer cells; Liver fibrosis; LPS receptor; macrophages

Indexed keywords

CD14 ANTIGEN; ENDOTOXIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE;

BILE DUCT ATRESIA; BILE DUCT OBSTRUCTION; CELLULAR DISTRIBUTION; CHOLANGITIS; CHOLESTASIS; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE EXPRESSION; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KUPFFER CELL; MACROPHAGE FUNCTION; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS;

EID: 0030064637     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(96)90333-4     Document Type: Conference Paper

References (27)

1. Morris JS, Gallo GA, Scheuer PJ, et al: Percutaneous liver biopsy in patients with large bile duct obstruction. Gastroenterology 68:750-754, 1975
2. 4 treated rat livers induce skin fibroblasts and liver fat storing cells proliferation in culture. Matrix 9:150-158, 1989
3. Armendariz-Borunda J, Seyer JM, Postlethwaite AE, et al: Kupffer cells from carbon tetrachloride injured livers produce chemotactic factors for fibroblasts and monocytes. Hepatology 14:898-900, 1991
4. Hines JE, Johnson SJ, Burt AD: In vivo responses of macrophages and perisinoidal cells to cholestatic liver injury. Am J Pathol 142:511-517, 1993
5. Dillon P, Belchis D, Tracy T, et al: Increased expression of intercellular adhesion molecules in biliary atresia. Am J Pathol 145:263-267, 1994
6. Fox ES, Leingang K, Johnson B, et al: Early liver injury alters hepatic macrophage phenotype and function. Hepatology 20:198A, 1994
7. Tracy TF Jr, Fox ES: CD14-lipopolysaccharide receptor activation in hepatic macrophages following cholestatic liver injury. Surgery 118:371-377, 1995
8. Wright SD, Ramos RA, Tobias PS, et al: CD14, a receptor for complexes of lipopolysaccharide and LPS binding protein. Science 249:1431-1433, 1990
9. Fox ES, Hafenrichter DG, Flye MW: Lipopolysaccharide stimulation of isolated Kupffer cells is a CD14 independent process. Hepatology 20:450A, 1994
10. Kitchen S, Tracy TF, Vogler C, et al: A model of reversible obstructive liver injury-patterns of matrix and cellular modulation. Lab Invest 68:6P, 1993
11. Altman RP, Chandra R, Lilly JR: Ongoing cirrhosis after successful portoenterostomy. J Pediatr Surg 10:685-691, 1995
12. Desmet VJ: Extrahepatic bile ducts under the lens. J Hepatol 1:545-559, 1987
13. Tilg H, Wilmer A, Vogal W, et al: Serum levels of cytokines in chronic liver disease. Gastroenterology 103:264-74, 1992
14. Tobias PS, Soldau K, Kline L, et al: Cross linking of LPS to CD 14 on THP-1 cells mediated by LPS-binding protein. J Immunol 150:3011-3021, 1993
15. Diamond T, Dolan S, Thompson RL, et al: Development and reversal of endotoxemia and endotoxin-related death in obstructive jaundice. Surgery 108:370-374, 1990
16. Maggiore G, De Giacomo C, Scotta MS, et al: Cell mediated immunity in children with chronic cholestasis. J Pediatr Gastroenterol Nutr 1:385-388, 1982
17. Barclay RG, Rowlands BJ: Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg 128:200-205, 1993
18. Bemelmans MH, Gouma DJ, Greve JW, et al: Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. Hepatology 15:1132-1136, 1992
19. Callery MP, Mangino MJ, Flye MW: A biologic basis for limited Kupffer cell reactivity to portal-derived endotoxin. Surgery 110:221-230, 1991
20. Tomita M, Yamamoto K, Kobashi H, et al: Immunohistochemical phenotyping of liver macrophages in normal and diseased human liver. Hepatology 20:317-325, 1994
21. Ferrero E, Jiao D, Tsuberi BZ, et al: Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide. Proc Natl Acad Sci USA 90:2380-2384, 1993
22. Laurent J, Gauthier F, Bernard O, et al: Long-term outcome after surgery for biliary atresia. Study of 40 patients surviving for more than lOyears. Gastroenterology 99:1793-1797, 1990
23. Lally KP, Kanegaye J, Matsumura M, et al: Perioperative factors affecting the outcome following repair of biliary atresia. Pediatrics 83:723-726, 1989
24. Burnweit CA, Coin D: Influence of diversion on the development of cholangitis after hepatoportoenterostomy for biliary atresia. J Pediatr Surg 21:1143-1146, 1986
25. Rothenberg SS, Schroter GP, Karrer FM, et al: Cholangitis after the Kasai operation for biliary atresia. J Pediatr Surg 24:729-732, 1989
26. Nakajo T, Hashizume K, Saeki M, et al: Intussusception-type antireflux valve in the Roux-en-Y loop to prevent ascending cholangitis after hepatic portojejunostomy. J Pediatr Surg 25:311-314, 1990
27. Mones RL, DeFelice AR, Preud'Homme D: Use of neomycin as the prophylaxis against recurrent cholangitis after Kasai portoenterostomy. J Pediatr Surg 29:422-424, 1994